Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
---|
07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
07/01/2004 | WO2004055000A1 Multifunctional cationic photoinitiators, their preparation and use |
06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
06/29/2004 | CA2133089C Novel cyclic amino acids and derivatives thereof |
06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
06/24/2004 | DE10249324A1 Polymerisationsfähige bicyclische Cyclopropanderivate und deren Verwendung zur Herstellung von Dentalmaterialien Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
06/23/2004 | EP1431298A1 Mannitol and glucitol derivatives |
06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
06/17/2004 | WO2004018414A3 Antibacterial agents |
06/17/2004 | US20040116508 1-(N,N-bischloroethylaminoethoxy)-4-tert-butyldimethylsilyloxythioxanthone; administering first then sodium fluoride; tissue targeted therapy; administering in nontoxic, protodrug form which accumulates in neoplasm, followed by an activation drug |
06/17/2004 | US20040116445 Substituted thioacetamides |
06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
06/17/2004 | CA2507484A1 Substituted ureas and carbamates |
06/15/2004 | US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
06/09/2004 | EP1426361A1 Novel composition containing a bi-cyclic compound and a glyceride |
06/08/2004 | US6747149 Glucamine salts for treating hepatitis virus infections |
06/03/2004 | WO2004045557A2 Novel lapachone compounds and methods of use thereof |
06/03/2004 | CA2506340A1 Novel lapachone compounds and methods of use thereof |
06/02/2004 | EP1424127A1 Thiopyryl cation and derivatives of same trapped in a zeolitic material |
05/27/2004 | WO2004029019A3 Compounds for the treatment of alzheimer’s disease |
05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
05/26/2004 | CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists |
05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
05/20/2004 | US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity |
05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
05/19/2004 | EP1220849B1 Bicyclic compounds composition and method for stabilizing the same |
05/19/2004 | CN1496975A Emodin derivative with anti-tumour activity |
05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
05/13/2004 | WO2004024709A3 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
05/12/2004 | EP1417198A2 Sulfonium salts as photoinitiators for radiation curable systems |
05/12/2004 | EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors |
05/12/2004 | EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
05/12/2004 | CN1495181A Method for preparing cyclic oxazolidone containing sulfur and fluorine |
05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
05/12/2004 | CN1149211C Benzoyl derivatives, method for producing them and their use as herbicids and plant growth regulators |
05/11/2004 | US6734203 Fused imidazolium derivatives |
05/06/2004 | WO2004037879A2 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom |
05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
05/05/2004 | CN1148346C Hydrazine derivs. |
05/04/2004 | US6730697 For use as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an infarction and therapy of infarction, and for treatment of angina pectoris |
04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
04/29/2004 | US20040082601 Anti-inflammatory compounds |
04/28/2004 | EP1413569A1 Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials |
04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
04/22/2004 | US20040077882 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
04/14/2004 | EP1406699A1 Antitumoral formulations of thioxanthenone |
04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
04/08/2004 | WO2004029019A2 Compounds for the treatment of alzheimer’s disease |
04/08/2004 | WO2004000889A3 Polymeric photoinitiators |
04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
04/08/2004 | CA2500109A1 Compounds for the treatment of alzheimer's disease |
04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
04/06/2004 | CA2223927C Detection of transmembrane potentials by optical methods |
04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
03/30/2004 | US6713636 Having utility as fluorescent dyes |
03/30/2004 | US6713580 Quaternary amino acids on solid supports |
03/25/2004 | WO2004024709A2 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
03/25/2004 | WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
03/25/2004 | WO2004024086A2 Compounds, compositions and methods |
03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/25/2004 | US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof |
03/25/2004 | US20040059145 Heterodiamondoids |
03/25/2004 | US20040059133 Process for the production of substituted thioxanthones |
03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/25/2004 | CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
03/24/2004 | EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders |
03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
03/18/2004 | US20040053907 Cell adhesion inhibitors |
03/18/2004 | CA2501924A1 Non-nucleoside reverse transcriptase inhibitors |
03/17/2004 | CN1142158C Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
03/10/2004 | CN1481392A Surface-active photoinitiators |
03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
03/04/2004 | WO2004018414A2 Antibacterial agents |
03/04/2004 | WO2003078646A3 Aza-thioxanthenones with antitumor activity |
03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |